Tatiana A. Lisitsyna

Moscow, MOW, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Olokizumab Improves Patient-Reported Outcomes in Patients with Active Rheumatoid Arthritis up to 106 Weeks (Results from the Open-Label Extension of Phase III Randomized Clinical Trials).

Olokizumab Improves Patient-Reported Outcomes in Patients with Active Rheumatoid Arthritis up to 106 Weeks (Results from the Open-Label Extension of Phase III Randomized Clinical Trials).

Journal: Rheumatology and therapy

Published: December 08, 2025

Efficacy of Olokizumab in Treating Comorbid Depression in Patients with Rheumatoid Arthritis: Results of a Single-Center Randomized Controlled Trial.

Efficacy of Olokizumab in Treating Comorbid Depression in Patients with Rheumatoid Arthritis: Results of a Single-Center Randomized Controlled Trial.

Journal: Doklady. Biochemistry and biophysics

Published: October 20, 2025

To the problem of extended serological testing for viral hepatitis B in rheumatoid arthritis patients

To the problem of extended serological testing for viral hepatitis B in rheumatoid arthritis patients

Journal: Terapevticheskii arkhiv

Published: February 11, 2025

Cognitive Impairments in Patients with Rheumatoid Arthritis and Comorbid Anxiety and Depressive Disorders: Outcomes of the Five-Year Prospective Study.

Cognitive Impairments in Patients with Rheumatoid Arthritis and Comorbid Anxiety and Depressive Disorders: Outcomes of the Five-Year Prospective Study.

Journal: Doklady. Biochemistry and biophysics

Published: February 03, 2025

Autoantigenic peptide landscape of rheumatoid arthritis-associated HLA class II.

Autoantigenic peptide landscape of rheumatoid arthritis-associated HLA class II.

Journal: Genes & diseases

Published: August 12, 2024

Efficacy of Olokizumab against Comorbid Depressive Disorder in Patients with Rheumatoid Arthritis: Preliminary Results of the Study.

Efficacy of Olokizumab against Comorbid Depressive Disorder in Patients with Rheumatoid Arthritis: Preliminary Results of the Study.

Journal: Doklady. Biochemistry and biophysics

Published: April 04, 2024

Mental disorders in patients with systemic lupus erythematosus: association with activity and the course of rheumatic disease

Mental disorders in patients with systemic lupus erythematosus: association with activity and the course of rheumatic disease

Journal: Terapevticheskii arkhiv

Published: July 16, 2023

Comparative assessment of sensitivity and specificity of three variants of classification criteria for systemic lupus erythematosus in a cohort of Russian patients

Comparative assessment of sensitivity and specificity of three variants of classification criteria for systemic lupus erythematosus in a cohort of Russian patients

Journal: Terapevticheskii arkhiv

Published: July 16, 2023

Successful psychopharmacotherapy of anxiety and depressive disorders improve functional limitations in patients with rheumatoid arthritis

Successful psychopharmacotherapy of anxiety and depressive disorders improve functional limitations in patients with rheumatoid arthritis

Journal: Terapevticheskii arkhiv

Published: June 16, 2022

Anxiety-depressive disorders and stress factors in patients with systemic lupus erythematosus and antiphospholipid syndrome

Anxiety-depressive disorders and stress factors in patients with systemic lupus erythematosus and antiphospholipid syndrome

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Published: April 08, 2022

Influence of successful psychopharmacotherapy of anxiety-depressive spectrum disorders on the severity of chronic fatigue in patients with rheumatoid arthritis

Influence of successful psychopharmacotherapy of anxiety-depressive spectrum disorders on the severity of chronic fatigue in patients with rheumatoid arthritis

Journal: Terapevticheskii arkhiv

Published: May 15, 2021

Mental disorders and cognitive impairment in patients with antiphospholipid syndrome

Mental disorders and cognitive impairment in patients with antiphospholipid syndrome

Journal: Terapevticheskii arkhiv

Published: June 04, 2020

Showing 1-12 of 25

Last Updated: 09/26/2026